Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Pascal Deschatelets. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Pascal Deschatelets reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:APLS / Apellis Pharmaceuticals, Inc. Chief Scientific Officer 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Pascal Deschatelets. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Pascal Deschatelets conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -25,840 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -11,284 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -3,372 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -4,909 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -25,840 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 25,840 25,840
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -12,920 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 12,920 12,920
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -10,030 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 10,030 10,030
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -41,250 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 41,250 41,250
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
U - Other -1,177,222 0 -100.00
2026-01-30 2026-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 25,840 1,177,222 2.24
2026-01-23 2026-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -5,928 1,151,382 -0.51 21.77 -129,025 25,060,290
2026-01-21 2026-01-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -909 1,157,310 -0.08 19.79 -17,992 22,906,521
2026-01-15 2026-01-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -2,277 1,158,219 -0.20 22.19 -50,520 25,697,637
2025-05-22 2025-05-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 12,780 1,160,496 1.11 3.76 48,053 4,363,465
2025-01-30 2025-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -826 1,147,716 -0.07 29.52 -24,386 33,884,708
2025-01-23 2025-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -3,948 1,148,542 -0.34 30.43 -120,120 34,944,965
2025-01-21 2025-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 15,045 1,152,490 1.32
2025-01-21 2025-01-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -750 1,137,445 -0.07 29.96 -22,469 34,075,805
2025-01-14 2025-01-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -2,288 1,138,195 -0.20 28.70 -65,670 32,668,587
2024-05-21 2024-05-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 24,500 1,140,483 2.20 3.76 92,120 4,288,216
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,115,983 -0.01 44.02 -4,402 49,131,152
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -22,472 1,116,083 -1.97 42.85 -962,903 47,823,040
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -56,335 1,138,555 -4.71 42.15 -2,374,543 47,990,549
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 78,907 1,194,890 7.07 4.31 340,089 5,149,976
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,728 1,115,983 -0.42 54.92 -259,639 61,284,430
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -64,379 1,120,711 -5.43 54.12 -3,483,966 60,648,957
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 69,107 1,185,090 6.19 3.76 259,842 4,455,938
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,115,983 -0.01 63.35 -6,335 70,697,523
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -26,257 1,116,083 -2.30 62.69 -1,646,041 69,966,797
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -42,750 1,142,340 -3.61 61.88 -2,645,173 70,682,744
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 69,107 1,185,090 6.19 3.67 253,623 4,349,280
2024-02-13 2024-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -1,148 1,115,983 -0.10 67.77 -77,796 75,626,708
2024-01-31 2024-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -874 1,117,131 -0.08 64.14 -56,057 71,650,772
2024-01-23 2024-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -3,913 1,118,005 -0.35 65.00 -254,329 72,665,853
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -1,632 1,121,918 -0.15 66.81 -109,032 74,953,771
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 6,743 1,123,550 0.60
2023-11-15 2023-11-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 45,000 1,116,807 4.20 3.76 169,200 4,199,194
2023-11-09 2023-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,071,807 -1.11 47.27 -567,240 50,664,317
2023-11-09 2023-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 17,494 1,083,807 1.64 2.67 46,709 2,893,765
2023-10-10 2023-10-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,066,313 -1.11 40.38 -484,560 43,057,719
2023-10-10 2023-10-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,078,313 1.75 2.67 49,395 2,879,096
2023-09-11 2023-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -12,000 1,059,813 -1.12 42.87 -514,440 45,434,183
2023-09-11 2023-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,071,813 1.76 2.67 49,395 2,861,741
2023-08-09 2023-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,053,313 -1.13 23.66 -283,920 24,921,386
2023-08-09 2023-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,065,313 1.77 2.67 49,395 2,844,386
2023-07-11 2023-07-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,046,813 -1.13 84.55 -1,014,600 88,508,039
2023-07-11 2023-07-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,058,813 1.78 2.67 49,395 2,827,031
2023-06-09 2023-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,040,313 -1.14 91.35 -1,096,200 95,032,593
2023-06-09 2023-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,052,313 1.79 2.67 49,395 2,809,676
2023-05-09 2023-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,033,813 -1.15 92.39 -1,108,680 95,513,983
2023-05-09 2023-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,045,813 1.80 2.67 49,395 2,792,321
2023-04-11 2023-04-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,027,313 -1.15 78.21 -938,520 80,346,150
2023-04-11 2023-04-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,039,313 1.81 2.67 49,395 2,774,966
2023-03-10 2023-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,020,813 -1.16 63.79 -765,480 65,117,661
2023-03-10 2023-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,032,813 1.82 2.67 49,395 2,757,611
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,195 1,014,313 -0.12 58.50 -69,908 59,337,310
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 9,886 1,015,508 0.98
2023-02-14 2023-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,134 1,005,622 -0.11 51.21 -58,072 51,497,903
2023-02-10 2023-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,006,756 -1.18 54.45 -653,400 54,817,864
2023-02-10 2023-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,018,756 1.85 2.67 49,395 2,720,079
2023-01-30 2023-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -832 1,000,256 -0.08 52.77 -43,905 52,783,509
2023-01-24 2023-01-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -2,326 1,001,088 -0.23 52.05 -121,068 52,106,630
2023-01-17 2023-01-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 19,634 1,003,414 2.00
2023-01-10 2023-01-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 983,780 -1.21 46.08 -552,960 45,332,582
2023-01-10 2023-01-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 995,780 1.89 2.67 49,395 2,658,733
2022-12-30 2022-12-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 7,000 977,280 0.72 3.67 25,690 3,586,618
2022-12-12 2022-12-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 970,280 -1.22 47.50 -570,000 46,088,300
2022-12-12 2022-12-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 982,280 1.92 2.67 49,395 2,622,688
2022-11-10 2022-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 963,780 -1.23 46.47 -557,640 44,786,857
2022-11-10 2022-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 975,780 1.93 2.67 49,395 2,605,333
2022-10-11 2022-10-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 957,280 -1.24 57.50 -690,000 55,043,600
2022-10-11 2022-10-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 969,280 1.95 2.67 49,395 2,587,978
2022-09-12 2022-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 950,780 -1.25 63.98 -767,760 60,830,904
2022-09-12 2022-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 962,780 1.96 2.67 49,395 2,570,623
2022-08-09 2022-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 944,280 -1.25 62.50 -750,000 59,017,500
2022-08-09 2022-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 956,280 1.97 2.67 49,395 2,553,268
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 937,780 -1.26 47.95 -575,400 44,966,551
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,500 949,780 0.69 2.67 17,355 2,535,913
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 12,000 943,280 1.29 2.67 32,040 2,518,558
2022-06-22 2022-06-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 33,005 931,280 3.67 2.67 88,123 2,486,518
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,500 898,275 0.73 2.67 17,355 2,398,394
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 891,775 -1.33 44.09 -529,080 39,318,360
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 12,000 903,775 1.35 2.67 32,040 2,413,079
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -4,000 364,999 -1.08
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,000 891,775 -0.45 44.43 -177,720 39,621,563
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 4,000 895,775 0.45 2.67 10,680 2,391,719
2022-05-02 2022-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
J - Other -11,250 0 -100.00
2022-05-02 2022-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other -1,875 891,775 -0.21
2022-02-14 2022-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,057 893,650 -0.12 47.12 -49,806 42,108,788
2022-02-01 2022-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -931 894,707 -0.10 38.59 -35,927 34,526,743
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 36,951 36,951
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 26,051 895,638 3.00
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 368,999 -1.67
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 869,587 -0.71 65.61 -410,062 57,053,603
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 875,837 0.72 2.67 16,688 2,338,485
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 375,249 -1.64
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 869,587 -0.71 47.40 -296,250 41,218,424
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 875,837 0.72 2.67 16,688 2,338,485
2021-04-29 2021-04-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -4,500 381,499 -1.17
2021-04-29 2021-04-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 4,500 869,587 0.52 2.67 12,015 2,321,797
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 385,999 -1.59
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 865,087 -0.72 46.13 -288,312 39,906,463
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 871,337 0.72 2.67 16,688 2,326,470
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -6,250 392,249 -1.57
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -6,250 865,087 -0.72 50.74 -317,125 43,894,514
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 6,250 871,337 0.72 2.67 16,688 2,326,470
2021-02-11 2021-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -688 865,087 -0.08 47.72 -32,831 41,281,952
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 11,250 11,250
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 45,000 45,000
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 1,875 865,775 0.22
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 7,500 863,900 0.88
2020-03-12 2020-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -161,656 847,025 -16.03
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -117,205 0 -100.00
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -55,398 1,008,681 -5.21 40.98 -2,270,155 41,334,739
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 117,205 1,064,079 12.38 2.14 250,819 2,277,129
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -117,206 117,205 -50.00
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -52,075 946,874 -5.21 42.80 -2,228,966 40,529,048
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 117,206 998,949 13.29 2.14 250,821 2,137,751
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy)
A - Award 56,250 56,250
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 9,375 891,118 1.06
2019-09-26 2019-09-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,010 881,743 -0.11 25.64 -25,897 22,608,772
2019-09-26 2019-09-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,531 882,753 -2.27 25.24 -518,161 22,278,920
2019-09-25 2019-09-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,295 903,284 -0.14 24.96 -32,321 22,544,162
2019-09-25 2019-09-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,307 904,579 -2.20 24.56 -498,760 22,217,365
2019-09-25 2019-09-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 924,886 -0.01 25.53 -2,553 23,612,340
2019-09-25 2019-09-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,758 924,986 -2.19 25.07 -520,362 23,187,549
2019-02-12 2019-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy)
A - Award 95,000 95,000
2018-05-09 2018-05-07 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other 384,292 945,744 68.45
2018-02-21 2018-02-16 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 110,000 110,000
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
1,122,904
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
1,122,904
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)